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Take home message: Ventilation distribution on MRI improves at TLC and two 
distinct patterns of regional lung disease in CF are highlighted, where abnormal 
FEV1 is associated with VDP >10%. Ventilation MRI & MBW are highly correlated. 
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Glossary 
 
CF Ȃ Cystic fibrosis 
EIVt Ȃ End-inspiratory tidal volume 
FEV1 Ȃ Forced expiratory volume in 1 second 
FRC  -Functional residual capacity 
3He Ȃ Helium-3 
LCI Ȃ Lung clearance index 
MBW Ȃ Multiple breath washout 
MRI Ȃ Magnetic resonance imaging 
RV Ȃ Residual volume 
Scond Ȃ convection dependent ventilation heterogeneity 
Sacin - convection-diffusion dependent ventilation heterogeneity 
TCV Ȃ Thoracic cavity volume 
TLC Ȃ Total lung capacity 
VDP Ȃ Ventilation defect percentage 
VHI Ȃ Ventilation heterogeneity index 
VV Ȃ Ventilated volume  
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Abstract (200 words) 
 
Hyperpolarised helium-3 (3He) ventilation MRI and multiple-breath washout 
(MBW) are sensitive methods for detecting lung disease in cystic fibrosis (CF). We 
aimed to explore their relationship across a broad range of CF disease severity and 
patient age, as well as assess the effect of inhaled lung volume on ventilation 
distribution. 
 
32 children and adults with CF underwent MBW and 3He-MRI at a lung volume of 
end-inspiratory tidal volume (EIVt). 28 patients also performed 3He-MRI at total 
lung capacity (TLC). 3He-MRI were quantitatively analysed for; ventilation defect 
percentage (VDP), ventilation heterogeneity index (VHI), and the number and size 
of individual contiguous ventilation defects. From MBW, the lung clearance index 
(LCI), Scond and Sacin were calculated.  
 
VDP and VHI at EIVt strongly correlated with LCI (r=0.89,r=0.88 respectively), Sacin 
(r=0.84,r=0.82) and FEV1 (r=-0.79,r=-0.78). Two distinct 3He-MRI patterns were 
highlighted; patients with abnormal FEV1 had significantly (p<0.001) larger, but 
fewer contiguous defects than those with normal FEV1 who tended to have 
numerous small volume defects. These two MRI patterns were delineated by a 
VDP of approximately 10%. At TLC, when compared to EIVt, VDP and VHI reduced 
in all subjects (p<0.001), demonstrating improved ventilation distribution and 
also regions of volume-reversible and non-reversible ventilation abnormalities. 
 
Introduction 
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Hyperpolarised gas ventilation MRI allows for detailed and sensitive quantitative 
assessment of regional lung ventilation abnormalities in patients with obstructive 
airways disease [1-4]. The MRI technique usually involves the inhalation of a fixed 
volume of hyperpolarised noble gas and the resulting distribution of ventilation is 
imaged during a short breath-hold. In patients with cystic fibrosis (CF) it has been 
shown to be highly sensitive to detect early lung disease in children [5, 6], to track 
disease progression [7] and to assess treatment response [8]. The use of a fixed 
inhalation volume however, will result in patients with smaller lung volume being 
closer to their total lung capacity (TLC) than patients with larger lung volume. The 
effect that this has on the distribution of ventilation has not yet been assessed in 
CF. In addition, understanding the nature and pattern of regional ventilation 
defects seen on MRI, across the spectrum of CF lung disease, will allow for a 
greater understanding of lung disease pathophysiology and progression.  
 
The lung clearance index (LCI), derived from multiple-breath washout (MBW) is 
a physiological measure of global ventilation heterogeneity that is sensitive to 
early lung disease [9]. LCI correlates with structural abnormalities seen on CT [10-
12] and MRI [13] and is also sensitive to treatment response [14]. The utility of 
LCI in CF has been established primarily in children and patients with mild 
disease. In more severe CF lung disease, when previously obstructed regions open 
up to tidal ventilation due to treatment, the LCI response is unpredictable and may 
worsen despite improvements in FEV1 [15-19]. Comparing LCI to ventilation MRI 
may therefore help to better understand ventilation abnormalities expressed by 
the two methods. 
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In this work we therefore aimed to:  
(1) Compare ventilation MRI and MBW, including LCI and the phase III slope 
outcomes Scond (convection dependent ventilation heterogeneity) and Sacin 
(convection-diffusion dependent ventilation heterogeneity), in children and 
adults with CF with a broad range of lung disease severity.  
(2) Assess ventilation MRI at two different lung volumes in order to investigate 
the nature of reversible airway obstruction in CF.  
(3) Assess the relationship between size and number of individual contiguous 
ventilation defects from ventilation MRI in CF patients across a broad range of 
disease severity to aid understanding of regional imaging data and disease status. 
 
Methods 
 
Children and adults with CF were recruited from three UK specialist centres ȋ ǯ    
 ǡ ǡ  
Manchester Adult CF Centre, Manchester, UK). Patients were required to be aged 
over five years, be clinically stable for four weeks prior to their visit and achieve 
an FEV1 >30% predicted within the previous six months. This study was approved 
by the Yorkshire and Humber - Leeds West Research Ethics Committee (REC 
reference: 16/YH/0339). Parents/guardians of children and all adult patients 
provided written informed consent. 
MRI acquisition 
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Ventilation MRI was performed on a 1.5T GE HDx scanner (GE, Milwaukee, USA) 
using hyperpolarised helium-3 (3He) using a transmit-receive vest coil (CMRS, 
Milwaukee, USA) and a 3D ventilation imaging sequence as described previously 
[20]. Images were acquired at two different lung inhalation volumes during 
separate breath-holds. Firstly, images were acquired at a lung volume 
corresponding to end-inspiratory tidal volume (EIVt), by inhaling a pre-
determined fixed volume of test gas from their resting functional residual capacity 
(FRC). This corresponds to the approximate inspired volume most typically 
reported in studies to date [1, 5, 6, 8, 21-28]. The volume of gas was titrated based   ǯ  3He and balanced with 
nitrogen (N2) (E-Table 1). Secondly, images were acquired at TLC by repeating the 
EIVt-breathing manoeuvre, immediately followed by a full inhalation of room air. 
Further methodological details are described in the OLS. 
 
MRI Post-Processing 
For both the EIVt and TLC 3He and 1H image pairs, image metrics were calculated 
from a semi-automated segmentation [29]. The 3He images were segmented in 
order to calculate the ventilated lung volume (VV) and the 1H images were used to 
calculate the thoracic cavity volume (TCV). From these two segmentations the 
ventilation defect percentage (VDP) and the ventilation heterogeneity index (VHI) 
were calculated (See Table 1 and OLS).  
 
Contiguous individual ventilation defects in 3D were assessed. Defects that 
contributed to <1% of total VDP were discarded. The number of remaining defects 
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(Ndefects), as well as the volume of individual defects were calculated.  The image 
analysis workflow is summarised in E-Figure 2. 
 
To describe the degree of ventilation change from EIVt to TLC, the reversible-
volume index was calculated from the EIVt and TLC images by:  
 
Reversible-volume index = 
ሺ୼୚୚ሻሺ୼୘େ୚ሻ 
 
Where ȴVV = VV(TLC) Ȃ VV(EIVt) and ȴTCV = TCV(TLC) Ȃ TCV(EIVt). Finally, the 
difference in VHI ȋȟVHI) was quantified by: ȟI = VHI (TLC) ȂVHI (EIVT). 
 
Pulmonary Function 
 
MBW was performed as previously described using a modified open-circuit 
Innocor and 0.2% SF6 [30]. MBW was performed in triplicate both seated and 
supine [31]. From MBW, the metrics; lung clearance index (LCI), Scond and Sacin 
were calculated and the average taken from at least two technically acceptable 
trials. Spirometry and body plethysmography were performed to international 
standards [32, 33] Ǯ	ǯ (Vyaire, Basingstoke, UK) and recommended 
reference equations [34]. All tests were performed on the same day. Either MBW 
or MRI was performed first, followed by the other. Spirometry was always 
performed last. 
Statistical analysis 
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Metrics were assessed for normality using the Shapiro-Wilks test and expressed 
as either the mean (SD) or the median (range). Patients were grouped into three 
groups; group 1 consisted of patients with normal FEV1 (>-1.64 z-score) and 
normal LCI (<7.4 [30]); group 2 had normal FEV1 but abnormal LCI (>7.4); and 
group 3 had both abnormal FEV1 and LCI. Group comparisons were assessed using 
the Kruskal-  ǯ   Ǥ As a result of this 
analysis, two refined groups are referred to throughout the results; those with 
normal FEV1 (z-score >-1.64) and those with abnormal FEV1 (z-score <-1.64). ǯ        
between metrics. In total 13 metrics were considered, therefore after Bonferroni 
adjustment [35], a p-value <0.004 was considered significant for correlation 
analysis. The Wilcoxon-signed rank test was used to assess the difference in MRI 
metrics between EIVt and TLC. All analyses were performed in GraphPad Prism 
(V7.0, San Diego, US). 
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Table 1: Description of metrics calculated from 3He and 1H MRI  
Thoracic Cavity Volume 
(TCV) 
Calculated from the segmentation of the 1H anatomical MRI. The TCV is the lung volume at which 3He-MRI is 
performed and is measured in litres. 
Ventilated Volume (VV) 
Calculated from 3He ventilation image segmentation.  VV represents the volume of ventilated lung  and is measured 
in litres. 
Ventilation Defect 
Percentage (VDP) 
VDP is the percentage of the TCV that is not ventilated in the 3He MR images. Areas of the 3He image that contribute 
to VDP appear black. It is calculated as: VDP = 100-((VV/TCV)*100). Larger VDP values are associated with increased 
lung disease.  
Ventilation 
Heterogeneity Index 
(VHI) 
VHI is a marker of the heterogeneity of the 3He signal within ventilated regions of the 3He MR images. For each 
ventilated pixel, a local coefficient of variation of signal intensity in the surrounding pixels is computed. VHI is the 
inter-quartile range of the distribution of those values. Increased VHI is associated with increased ventilation 
heterogeneity and therefore increased lung disease. 
Number of ventilation 
defects (Ndefects) 
The number of individual 3D ǯǤ-ventilated 
lung areas contributing to VDP. Defects were counted if the defect volume was >1% of total VDP. 
Largest ventilation 
defect 
This is the volume of the largest contiguous ventilation defect within the lungs. It is measured in litres and also as a 
percentage of the TCV. 
Reversible-volume 
index 
This represents the relative change that occurs in VV in response to the increase in TCV when comparing EIVt to TLC 
images. The reversible-volume index is equal to at least 1.0, the larger the value above 1.0 the greater the degree of 
EIVt ventilation defects that have resolved at TLǤǯ-
reversible ventilation defects (resulting from complete obstruction), an increase in TCV due to deep inhalation, will 
result in equal increase in VV and the reversible-volume index will be 1. In contrast, any ventilation defect present at 
EIVt that at least partially resolves at TLC, will produce a reversible-volume index >1 (E-Figure 3). 
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Results 
 
32 patients with CF were recruited and assessed (17 (53%) female). Patient 
demographics, lung function and MRI metrics are presented in Table 2. Of the 32 
patients studied, all but one child had visible ventilation abnormalities on 
ventilation MRI at EIVt. E-Figure 4 shows representative 3He images for all 
patients. 30 patients (94%) had a VDP >2% at EIVt, the upper value from healthy 
controls previously reported [6]. In contrast, 26 (81%) patients had raised LCI and 
14 (44%) patients had abnormal FEV1. This resulted in six patients with normal 
FEV1 and LCI (Group 1), 12 patients with normal FEV1 but abnormal LCI (Group 
2) and 14 patients with abnormal FEV1 and LCI (Group 3). At EIVt, group 3 had 
significantly higher VDP, VHI, largest individual defect and a significantly lower 
total number of individual defects (p<0.001), than groups 1 and 2.  There was 
however no significant difference between groups 1 and 2 for these metrics, 
though a trend towards higher VHI was seen in group 2 (Figure 1). The only metric 
to significantly distinguish groups 1 and 2 was Scond (p=0.03). 
 
Table 2: Patient demographics, lung function and ventilation MRI metrics at End-
inspiratory tidal volume (EIVt). Results are displayed for the whole population and 
for the three groups of patients. Group 1 = patients with normal spirometry and LCI. 
Group 2 = patients with normal spirometry but abnormal LCI and group 3 = 
abnormal spirometry and LCI. Metrics are presented as mean ± standard deviation 
(SD), or median (range) depending on the distribution of individual metrics. FEV1 = 
forced expiratory volume in one second. RV/TLC = residual volume/total lung 
capacity. LCI = lung clearance index. Scond = convection dependent ventilation 
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heterogeneity. Sacin = convection-diffusion dependent ventilation heterogeneity. VDP 
= ventilation defect percentage. VHI = ventilation heterogeneity index. TCV = 
thoracic cavity volume. Ndefects = number of defects. * denotes p<0.05 versus Group 1. 
^ denotes p<0.05 versus Group 2. 
 
 Mean ± SD or Median (Range) 
All patients Group 1 Group 2 Group 3 
N. (N. (%female)) 32 (53%) 6 12 14 
Age (years) 16.7 (6.4, 43.1) 10.1 (6.4, 16.5) 12.7 (8.3, 17.4) 29.9 (14.9, 43.1)*^ 
Height (cm) 156.2 ± 17.7 137.0 ± 16.1 153.7 ± 16.3 166.4 ± 11.7* 
Weight (kg) 49.7 ± 18.4 32.8 ± 12.5 45.1 ± 15.1 60.9 ± 16.2* 
FEV1 (z-score) -1.8 ± 2.03 0.5 ± 1.2 -0.6 ± 0.7 -3.9 ± 0.9*^ 
RV/TLC (%) 33.9 (17.8, 52.6) 23.5 (19.9, 26.5) 24.9 (17.8, 35.3) 47.7 (31.6, 52.6)*^ 
LCI 10.0 (6.0, 17.8) 6.7 (6.0, 7.0) 7.9 (7.4, 10.3) 13.3 (8.3, 17.8)*^ 
Scond 0.07 ± 0.03 0.04 ± 0.02 0.08 ± 0.02* 0.09 ± 0.03* 
Sacin 0.14 (0.04, 0.55) 0.08 (0.04, 0.10) 0.10 (0.05, 0.19) 0.30 (0.14, 0.55)*^ 
LCIsupine 9.6 (6.2, 20.2) 6.9 (6.2, 8.3) 9.1 (7.0, 10.6) 14.1 (7.7, 20.2)*^ 
VDP (%) 14.9 (0.2, 45.0) 2.7 (0.2, 3.3) 4.2 (1.5, 9.2) 29.0 (9.5, 45.0)*^ 
VHI (%) 15.1 (6.7, 22.2) 8.9 (6.7, 11.3) 12.1 (9.3, 17.8) 20.1 (15.0, 22.2)*^ 
Largest defect (%TCV) 3.1 (0.03, 26.8) 0.7 (0.03, 1.3) 1.2 (0.1, 3.5) 15.2 (3.8, 26.8)*^ 
Ndefects  7 (2, 24) 16 (9, 18) 13 (4, 24) 3 (2, 7)*^ 
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Figure 2 demonstrates 3D ventilation MR images at EIVt with contiguous 
ventilation defects highlighted, examples shown are for a patient in group 2 and a 
patient in group 3.  
 
Correlations between lung function and MRI at EIVt 
 
VDP demonstrated significant correlation (p<0.001, Figure 3) with: LCI (r=0.89) 
and Sacin (r=0.84), but not Scond (r=0.32); VDP also correlated with RV/TLC 
(r=0.80) and FEV1 (r=-0.79). VHI demonstrated significant correlations with LCI 
(r=0.88) and Sacin (r=0.82), but not Scond (r=0.46 E-Figure 5); and with RV/TLC 
(r=0.78) and FEV1 (r=-0.78). Supine MBW results also demonstrated significant 
equivalent correlations and are documented in E-Table 2. 
 
The volume of the largest defect correlated significantly (p<0.001) with VDP 
(r=0.97, Figure 4), LCI (r=0.85), FEV1 (r=-0.80) and Sacin (r=0.79) and the number 
of defects demonstrated a significant correlation with VDP (r=-0.86), LCI (-0.75), 
FEV1 (r=0.75) and Sacin (r=-0.62).  
 
Ventilation MRI comparison between EIVt and TLC  
 
Ventilation images at both EIVt and TLC were successfully acquired from 28 
patients (Table 3). Two patients were excluded due to acquisition errors and two 
patients could not successfully coordinate the TLC breathing manoeuvre. The 
median (range) TCV measured from 1H MRI at EIVt was 78.2 (61.2,95.0)% of the 
TCV at TLC, which was significantly correlated to the FRCpleth/TLC ratio (a marker 
  13 
of lung hyperinflation) measured during body plethysmography (r=0.68). The 
TCV at TLC was 97.7 (85.0,107.7)% of the TLC measured during body 
plethysmography.  
 
Table 3: Ventilation MRI metrics for the 28 patients with images acquired at both 
end-inspiratory tidal volume (EIVt) and total lung capacity (TLC). Data is presented 
as median (range). VDP = ventilation defect percentage (%). VHI = ventilation 
heterogeneity index. TCV = thoracic cavity volume.  * denotes p<0.05 between lung 
volumes. 
 EIVt TLC 
VDP (%) 8.5 (1.5, 45.0) 4.2 (0.2, 35.3)* 
VHI (%) 15.2 (7.4, 22.2) 9.7 (5.7, 18.0)* 
Largest defect size (%TCV) 3.3 (0.1, 26.8) 2.0 (0.0, 20.8)* 
Ndefects  9 (2, 24) 8.5 (2, 19) 
Reversible-volume index 1.1 (1.0, 2.4) 
ȟVHI -4.1 (-1.5, - 8.3) 
 
At TLC there was a marked reduction in ventilation abnormalities. Signal intensity 
in ventilated regions of the lungs appeared more homogeneous, and in most 
patients some areas of un-ventilated lung became ventilated at TLC. This resulted 
in fewer ventilation defects at TLC for some patients whilst in others ventilation 
abnormalities remained (Figure 5). At TLC when compared to EIVt, there was a 
significant decrease (p<0.001, Figure 6) in MRI markers (expressed as median 
difference [95% confidence interval]) including: VDP -4.7 [-11.0,-2.2]%; VHI -4.1 
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[-5.6,-3.1]%; volume of the largest defect -47.3 [-160.1, -17.1]mL, and largest 
defect expressed as a percentage of TCV -1.7 [-4.3,-0.8]%. 10/28 patients had a 
reduction in Ndefects at TLC (p=0.2), all of whom had normal FEV1. The reversible-
volume index, ȟI, significantly correlated with VDP at EIVt (r=0.85) and 
with LCI (r=0.82, E-Figure 6), Sacin (r=0.75) and FEV1 (r=-0.74). The reversible-
volume index was significantly higher in group 3 than in groups 1 and 2 (p<0.001),      ?   ?Ǥ ȟ I was not significantly different between 
groups. 
 
VDP at TLC significantly correlated with LCI (r=0.85), Sacin (r=0.77), FEV1 (r=-0.79) 
and RV/TLC (r=0.86). VHI at TLC significantly correlated with LCI (r=0.82), Sacin 
(r=0.74), FEV1 (r=-0.84) and RV/TLC (r=0.86). 
 
Discussion 
 
In this study we present a detailed analysis of the relationship between MBW and 
hyperpolarised gas ventilation MRI in patients with CF, across a broad range of 
age and disease severity. This analysis confirms the strong relationships between 
global MRI and MBW metrics that have previously been reported in smaller cohort 
studies, performed across narrower ranges of age and disease severity [5-7]. 
Previous work has documented that patients with CF have ventilation defects 
evident on hyperpolarised gas MRI [1, 8, 21, 24, 36, 37], that the technique is 
reproducible and repeatable [21, 24] and that it can be used to assess regional 
response to treatment [8, 28]. Here we demonstrate what appear to be two 
distinct ventilation MRI patterns of CF lung disease; (i) patients who have 
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numerous smaller defects (and normal FEV1); and (ii), patients who have fewer 
but much larger contiguous defects, where FEV1 is invariably reduced.  We have 
also demonstrated that many of these ventilation abnormalities are lung volume 
dependent. When larger volumes are inhaled, some apparently obstructed 
airways open and allow gas to ventilate previously un-ventilated areas.  
 
This last observation has important implications from an imaging methodology 
perspective. Studies utilising hyperpolarised gas are often performed by inhaling 
fixed gas volumes, with one litre of gas inhaled from FRC being common [21-25]. 
This however results in smaller subjects being closer to their TLC than taller 
subjects, potentially reducing VDP and making cross-sectional comparisons 
challenging. Recent paediatric studies have titrated the inhaled volume based on 
measured or predicted lung volume [6, 7, 26, 27] and we recommend this practice 
for all patients with CF. It is important to note however that we have not directly 
compared the inhaled volume given in this study to a fixed 1 litre inhalation. 
 
The finding that only some ventilation defects decrease in size at TLC implies that 
regions of volume-reversible airways obstruction and regions of complete 
airways obstruction (that are fixed on the time-scale of the imaging session) co-
exist in CF lungs. The reversibility of defects with deep inhalation highlights the 
probable value of physiotherapy and exercise in opening these lung regions, and 
also the potential for ventilation MRI to aid targeted therapies to be applied to 
specific lung regions. The change in ventilation from EIVt to TLC was not uniform   ǡ   ǯ   
abnormal at TLC. Assessing the transient nature of these lung-volume dependent 
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ventilation defects longitudinally may provide insight into the progression of 
disease pathophysiology. 
 
The analysis of contiguous ventilation defects allows quantification and tracking 
of individual defects over time. Two distinct ventilation MRI patterns at EIVt are 
highlighted, which may represent different ends of the disease spectrum in CF. 
Figure 4 demonstrates that in those patients with normal FEV1, VDP is <10% and 
predominantly consists of numerous small-volume defects (possibly due to 
predominantly peripheral airways disease), which also appear more likely to be 
reversible. By the time FEV1 becomes abnormal however, VDP is invariably >10%. 
In these patients, VDP is dominated by fewer larger contiguous defects 
(suggesting widespread airways disease and lobar destruction), possibly in part 
due to smaller defects merging with disease progression. In addition, these larger 
defects are less likely to disappear with full inspiration, suggesting a significant 
proportion of peripheral lung is not being routinely ventilated during tidal 
breathing. Such regions are likely to harbour reservoirs of trapped mucus and 
inflammatory exudate, encouraging further lung inflammation and damage. These 
findings in part are in contrast to previous work [37-39], which reported that the 
number of ventilation defects increased with worsening lung disease. This is likely 
due to the two dimensional (2D) assessment of ventilation images in previous 
studies, resulting in individual defects that span multiple slices being classed as 
multiple defects. Whereas in this 3D assessment of ventilation defects, defects are 
shown to be contiguous and not independent between slices, resulting in fewer 
individual defects.  
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There is an intuitive relationship between ventilation MRI and MBW metrics, as 
they both assess the distribution of inhaled gas within the lungs. These data 
suggest this relationship is stronger when MRI was performed at EIVt when 
compared to TLC, due to the EIVt manoeuvre most closely representing the end-
inspiratory cycle of quiet breathing performed during MBW. Ventilation MRI has 
the advantage that the exact regional nature of this ventilation distribution can be 
assessed, including lung regions that are entirely blocked (and hence silent to 
MBW testing). In this cohort we found that LCI and Sacin had strong relationships 
with VDP and VHI and also with reversible-volume index. Scond however showed 
poor correlations due to the Ǯplateau effectǯ evident in E-figure 5, which occurs 
with increasing disease. This plateau has been reported previously [40], and 
suggests Scond is useful primarily as a marker of very early CF lung disease, 
highlighted by the finding that Scond was the only metric to significantly 
differentiate between groups 1 and 2. Convection-dependent ventilation 
heterogeneity therefore seems to be an early event in disease progression. Figure 
3 suggests a similar relationship may be evident when comparing LCI and VHI, 
albeit the plateau effect for VHI occurs at much higher levels of LCI. Up to this point, 
VHI is strongly associated with increasing LCI. It is possible that with increasing 
lung disease in an individual, areas of increased VHI become non-ventilated and 
contribute directly to VDP instead. 
 
Higher values for the reversible-volume index indicate that a greater proportion 
of EIVt ventilation defects receive ventilation at TLC, implying volume-reversible 
airway obstruction. Reversible-volume index showed significant correlations with 
both LCI and Sacin. We hypothesise that this positive correlation may indicate that 
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ventilation defects present at EIVt, which become ventilated at TLC, may be lung 
regions responsible for delayed gas washout during MBW. On the other hand, 
patients with large VDP but relatively low LCI may be explained by the presence 
of defects that are unable to achieve ventilation at TLC (i.e. low reversible-volume 
index), therefore these defects may not significantly contribute to the dynamic LCI 
signal (E-figures 6 and 7). The reversible-volume index may therefore help explain 
why an unpredictable LCI response is seen with treatments in more severe and 
acute CF lung disease, despite clinical and spirometric improvements. We 
postulate that a lower reversible-volume index in a subject with significant 
ventilation abnormalities will result in a relatively low LCI for their level of lung 
disease (E-figure 7). In response to treatment, we hypothesise that both the 
reversible-volume index and the LCI would increase in this case, caused by the 
opening of previously blocked lung regions to the MBW signal. 
 
There are limitations to this study that require consideration. Whilst we have 
reported large numbers of patients for a ventilation MRI study [1, 5, 6, 8, 21, 22, 
26, 27, 36, 37], there are still relatively small numbers of subjects in each sub-
group, which inevitably limits the generalizability of this comparison. In 
comparing ventilation MRI with MBW we also acknowledge that the inert gases 
used have different diffusivity within the lung. 3He has higher diffusivity in air 
when compared to SF6, suggesting SF6 may reveal larger ventilation defects if used 
in MR imaging. This has been reported when comparing 3He with 129Xe ventilation 
imaging in COPD [41]. A limitation of the individual defect analysis is that it 
assesses contiguous areas of signal void within the ventilation images, which are 
not necessarily anatomically contiguous. The larger defects evident in more 
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severe disease can in some cases be seen to merge across different lung lobes 
which are fed by distinct conducting airways and therefore do not represent a 
physiologically discrete defect caused by blockage of a single airway. Finally, in 
order to validate these cross-sectional findings, longitudinal data are required to 
determine whether the different patterns of ventilation observed behave as we 
predict on an individual basis over time. 
 
In conclusion, this work adds to a growing body of work highlighting the use of 
ventilation MRI in CF, and specifically the role of VDP as a potential clinical tool 
and endpoint in clinical trials. In particular two key novel aspects are highlighted 
that help define the clinical meaning and utility of the methodology. Firstly, we 
highlight a VDP value of 10%, which separates normal and abnormal FEV1 values, 
(the current clinical gold standard) and also appears to delineate a boundary 
between the two distinct ventilation imaging patterns described, i.e. numerous 
small defects versus fewer large defects. Secondly, we demonstrate the 
coexistence of reversible and non-reversible regions of airway obstruction in CF 
using ventilation imaging at different lung volumes. This has direct impact on the 
longitudinal monitoring ǯregionally 
specific treatment. 
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Figure Captions 
 
Figure 1: Kruskal-Wallis group comparison for VDP, VHI, number of defects and 
largest individual contiguous defect, calculated from ventilation MRI at EIVt. 
Group 1 have both normal FEV1 and LCI. Group 2 have normal FEV1 but abnormal 
LCI. Group 3 have abnormal FEV1 and LCI. In all graphs, group 3 is significantly 
different when compared to groups 1 and 2 (p<0.001), but there was no 
statistically significant difference between groups 1 and 2. 
 
Figure 2: Demonstrates representative ventilation images at EIVt from a patient 
from group 2 (top) and group 3 (bottom). For both patients, the first row is a 3D 
ventilation image and the second row is a 3D ventilation image with the 
segmented individual contiguous ventilation defects added in colour. The colours 
associated with defects are arbitrary, but each different colour represents a single 
different radiologically contiguous defect. For each patient the ventilation image 
is observed from various anatomical angles. The top patient has VDP = 5.4%, 
largest defect (pink) = 1.5% of the TCV, Ndefects = 18. LCI = 7.7, FEV1 z-score = -0.5. 
The bottom patient has VDP = 45.0%, largest defect (red) = 26.8% of the TCV, 
Ndefects = 3, LCI = 14.9, FEV1 z-score = -5.4.  
 
Figure 3: Scatter plots of VDP (top row) and VHI (bottom row), both performed at 
EIVt, against pulmonary function metrics, with Spearman correlation values 
(p<0.001 in all). 
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Figure 4: Scatter plots of the number of individual contiguous ventilation defects 
(Ndefects, top row) and the size of the largest individual contiguous defect (bottom 
row) at EIVt; against VDP at EIVt, LCI and FEV1. In each graph patients are divided 
into those with an FEV1 z-score <-1.64 (closed circles), or >-1.64 (open circles). 
For FEV1 the dashed line represents the lower limit of normal (-1.64) and for LCI 
the dashed line represents the upper limit of normal (7.4). All Spearman 
correlations have a p-value <0.001. 
 
Figure 5: Representative 3He ventilation MR images acquired at EIVt and TLC from 
three subjects, with representative 1H MRI. Subject A: FEV1 z-score = -0.5, LCI = 
7.7, RV/TLC = 22.4%. This subject has ventilation defects present at EIVt 
(VDP=5.4%), which largely disappear at TLC (VDP=0.4%), reversible-volume 
index = 1.2. Subject B: FEV1 z-score = -3.7, LCI = 17.8, RV/TLC = 50.3%. This subject 
has ventilation defects present at EIVt (VDP=39.5%), some of which remain at TLC 
(VDP=18.2%), reversible-volume index = 2.0. Subject C: FEV1 z-score = -1.1, LCI = 
7.4, RV/TLC = 24.8%. This subject has ventilation defects present at EIVt 
(VDP=6.5%), which largely remain at TLC (VDP=5.3%) and therefore has a low 
reversible-volume index (1.0). The cause of part of the non-reversible ventilation 
can be seen in the left lung on the 1H image where an area of significant mucus is 
present, corresponding to the ventilation defect seen on both EIVt and TLC 
ventilation images (see arrow). 
 
Figure 6: A comparison of ventilation MRI metrics between EIVt and TLC. At TLC 
there was a significant reduction in: VDP, VHI, and the largest individual 
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contiguous defect (p<0.001). The number of defects declined only for some 
subjects with normal FEV1 (10/28 patients). 
 
 
